Skip to main
DBD
DBD logo

DBD Stock Forecast & Price Target

DBD Analyst Ratings

Based on 2 analyst ratings
Buy
Strong Buy 50%
Buy 50%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Diebold Nixdorf Inc. is demonstrating robust financial performance, particularly in its Retail segment, which reported revenues of $255 million, reflecting an increase of 8.1% sequentially and 7.8% year-over-year. The company is on track to achieve substantial free cash flow growth, with an expected range of $190 million to $210 million in 2025, significantly up from $109 million in 2024, indicating a sustainable positive cash flow trend. Furthermore, expected gross margin expansions combined with strong year-over-year earnings per share growth in 2026 underscore the positive financial outlook for Diebold Nixdorf.

Bears say

Diebold Nixdorf faces a challenging outlook primarily due to technological missteps and an inability to consistently innovate, which could undermine both revenues and profitability in a highly competitive landscape. The company's Banking segment reported a slight decline in total gross margins, which reflects ongoing pricing pressures and a potential drop in product demand exacerbated by external economic factors. Additionally, the company faces significant risks associated with fluctuating tariffs, supply chain disruptions, and foreign exchange volatility that may hinder its operational agility and financial stability.

DBD has been analyzed by 2 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 50% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Diebold Nixdorf Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Diebold Nixdorf Inc (DBD) Forecast

Analysts have given DBD a Buy based on their latest research and market trends.

According to 2 analysts, DBD has a Buy consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $80, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $80, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Diebold Nixdorf Inc (DBD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.